New data on declining fertility in the United States points to a need for new efforts to better understand improving fertility outcomes in women who wait to have their children.

With breathtaking speed, 23andMe and Celmatix have finished recruiting and enrolling participants in a groundbreaking study on fertility. Launched in February, the study aimed to enroll 4,500 women. It can...

A study, led by researchers in Australia, found new genetic associations for endometriosis, a painful disorder that affects one in ten women, leaving many infertile.Published this week in the journal...

A new Fertility Research Community launched by the next-generation women’s health company Celmatix, and 23andMe, will use genetic and other data to uncover more on what impacts a woman’s ability to conceive.

As part of a massive study that includes the contributions from scores of researchers across the globe, scientists have found a dozen genetic markers linked to fertility, offering hope to...

An international team of scientists has identified two genetic variants that influence the odds of a mother having natural fraternal, non-identical, twins. Hamdi Mbarek The findings also offer more insight...

As part of a collaboration with 23andMe, the personalized medicine company Celmatix is looking to dramatically improve the diagnosis and treatment of infertility. Infertility affects a large portion of the...

As a woman ages her fertility naturally declines such that by the time she reaches menopause her “ovarian reserve” is depleted, meaning that she has few to no eggs – oocytes – remaining in her ovaries. In the first genetic study on this topic, researchers have identified some potential markers for ovarian reserve, both genetic and non-genetic.

Two universal milestones in a woman’s life are menarche, the first menstrual period in girls, and menopause, when menstruation stops. Research suggests that the age at which menarche and menopause occur is about 50% influenced by genetics.